As chief scientific officer and founding scientist at Elicio Therapeutics, Inc., Peter DeMuth (B.S. ’08, biochemistry; B.S. ’08, chemical engineering) leads a trailblazing effort to fight cancer, developing novel therapies that harness the power of the human immune system.
